Certara Inc

Certara, incorporated in 2008, is a global company with its headquarters in Princeton, New Jersey, United States. Its core business activities revolve around three primary segments: software, consulting services, and scientific research and development. The company specializes in bio-simulation, regulatory science, and software tools designed to advance drug discovery, development, and regulatory approval processes. The company is known for its proprietary software platforms and technologies that hold high esteem in the pharmaceutical and biotech industries. Among the key offerings, Phoenix stands out as a comprehensive tool for pharmacokinetic, pharmacodynamic, and toxicokinetic modeling and simulation. Another significant product is Simcyp, a leading simulator for the prediction of drug-drug interactions and pharmacokinetics in virtual human populations. Additionally, Certara offers the Trial Simulator, which enables the simulation of clinical trials to optimize their design and execution. Certara's products and services are in demand across the globe, serving a diverse clientele that includes pharmaceutical and biotechnology companies, academic entities, and regulatory agencies. The company has a strong presence in various regions including North America, Europe, and Asia, with the United States, European Union, United Kingdom, and Japan being some of its most important markets. (Powered by AI)